The latest industry happenings, all in one place.
Dr. Amie Smirthwaite
Science 37 announced that Mike Zaranek has joined the company as its chief financial officer.
Maetrics has appointed Dr. Amie Smirthwaite as Senior Director of the Global Clinical Practice.
Almac Group has welcomed confirmation from the EMA that, post-Brexit, Northern Ireland will remain in regulatory alignment with the EU, acknowledging that EU laws, in respect of medicinal products, shall continue to apply in Northern Ireland. The UK Government has now also confirmed that this will be the case.
Clinical Ink has implemented a study of a treatment for cytokine storm, the immunological reaction associated with severe cases of COVID-19, in just 15 business days.
Florence Healthcare is proud to name Melinda Rodriguez, Director of Regulatory Services at Elligo Health Research, as the winner of The Florence Effect initiative.
MedTech Breakthrough has announced that Perficient Inc. has been selected as the winner of the “Best Data Visualization Solution” award for its pharmacovigilance intelligence application, PV Hawk, in the fourth annual MedTech Breakthrough Awards program.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.